You have 0 pages in your custom report
More than 65 years ago, before the idea of a “triple bottom line” emerged as a framework for reporting a company’s social, economic and environmental sustainability, Our Credo offered a business philosophy that continues to drive a deep commitment to operating sustainably. It spells out our broad array of stakeholders -- patients and customers, employees, communities and shareholders— all of whom are touched by our economic impacts.
Through more than a century of change, Johnson & Johnson has been a company privileged to play a role in helping millions of people around the world live better, healthier lives. We are guided in everything we do by Our Credo and by four strategic principles: being broadly based in human health; operating in a decentralized manner; managing for the long term; and staying focused on our people and values.
Leveraging these principles, we are able to make meaningful, positive impacts on the health care concerns that matter most to our stakeholders and businesses.
Johnson & Johnson financial results can be found here
Research and Development Investments and Expenditures
In our efforts to continue to improve health care around the world and produce new products and services, Johnson & Johnson invests heavily in Research and Development (R&D). In 2010, $6.884 billion, or 11.1 percent of sales, was invested in research and development, reflecting our commitment to the importance of ongoing development of new and differentiated products and services to help address the world’s human health challenges and sustain long-term growth.
For more information: http://www.investor.jnj.com/investor-relations.cfm
The following outlines Johnson & Johnson advertising expenditures over the past several years: